PMID- 37043080
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230718
IS  - 2193-8261 (Print)
IS  - 2193-6544 (Electronic)
IS  - 2193-6544 (Linking)
VI  - 12
IP  - 2
DP  - 2023 Jun
TI  - Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute 
      Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An 
      Expert Opinion from India.
PG  - 261-274
LID - 10.1007/s40119-023-00312-x [doi]
AB  - The current recommendations by Indian experts who are focused on the challenges 
      in the management of patients with acute coronary syndrome (ACS) in rural areas, 
      due to limited catheterization (CATH) lab facilities and interventional 
      cardiologist coverage across the country, are described. 120 cardiologist experts 
      drafted recommendations during ten advisory board meetings conducted from April 
      to May 2022. Experts framed statements based on experience, collective clinical 
      judgment from practical experience, and available scientific evidence regarding 
      ACS. The consensus positioned fondaparinux as highly useful in non-CATH-lab-based 
      hospitals for patients diagnosed with non-ST elevation acute coronary syndrome 
      (NSTE-ACS) and ST elevation acute coronary syndrome (STE-ACS) patients who cannot 
      be shifted to percutaneous coronary intervention (PCI)-capable centres, or for 
      patients who are thrombolysed at peripheral centres.
CI  - (c) 2023. The Author(s).
FAU - Ray, Saumitra
AU  - Ray S
AD  - AMRI Hospital, Kolkata, India.
FAU - Shivdasani, Bharat
AU  - Shivdasani B
AD  - Jaslok Hospital, Mumbai, India. rishitamondal@drreddys.com.
FAU - Mohan, Jagdish Chander
AU  - Mohan JC
AD  - Institute of Heart and Vascular Disorders, Jaipur Golden Hospital, New Delhi, 
      India.
FAU - Shah, V T
AU  - Shah VT
AD  - Dr. V T Shah Diagnostic Centre & Clinic, Mumbai, 8595513162, India.
FAU - Hiremath, Jagdish
AU  - Hiremath J
AD  - Heart Transplant Department, Ruby Hall Clinic, Pune, India.
FAU - Karnik, Rajiv
AU  - Karnik R
AD  - Asian Heart Institute, Mumbai, India.
FAU - Desai, Bhupen
AU  - Desai B
AD  - Desai Heart Care Clinic, Mumbai, India.
FAU - Madan, Hemant
AU  - Madan H
AD  - Dharamshila Narayana Superspeciality Hospital, Delhi, India.
FAU - Garg, Rajeev
AU  - Garg R
AD  - Aware Gleneagles Global Hospitals, Hyderabad, India.
FAU - Christopher, Johann
AU  - Christopher J
AD  - Gurunanak Care Hospital, Hyderabad, India.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230412
PL  - England
TA  - Cardiol Ther
JT  - Cardiology and therapy
JID - 101634495
PMC - PMC10209367
OTO - NOTNLM
OT  - Acute coronary syndrome
OT  - Anticoagulant
OT  - Fondaparinux
OT  - Percutaneous coronary intervention
COIS- Saumitra Ray, Bharat Shivdasani, Jagdish Chander Mohan, V. T. Shah, Jagdish 
      Hiremath, Rajiv Karnik, Bhupen Desai, Hemant Madan, Rajeev Garg, and Johann 
      Christopher have nothing to disclose.
EDAT- 2023/04/13 06:00
MHDA- 2023/04/13 06:01
PMCR- 2023/04/12
CRDT- 2023/04/12 11:18
PHST- 2022/12/22 00:00 [received]
PHST- 2023/03/22 00:00 [accepted]
PHST- 2023/04/13 06:01 [medline]
PHST- 2023/04/13 06:00 [pubmed]
PHST- 2023/04/12 11:18 [entrez]
PHST- 2023/04/12 00:00 [pmc-release]
AID - 10.1007/s40119-023-00312-x [pii]
AID - 312 [pii]
AID - 10.1007/s40119-023-00312-x [doi]
PST - ppublish
SO  - Cardiol Ther. 2023 Jun;12(2):261-274. doi: 10.1007/s40119-023-00312-x. Epub 2023 
      Apr 12.